Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Reference

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Show additional data
do not include text mining results
include AMENDA results (Automatic Mining of Enzyme Data)
include FRENDA results (AMENDA + additional results, but less precise)

Search term:

Results 1 - 10 of 29 > >>
EC Number BRENDA No. Title Journal Volume Pages Year Organism PubMed ID
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.47644058 Molecular modeling of the HIV-2 protease Adv. Exp. Med. Biol. 306 549-553 1991 Human immunodeficiency virus 2 1812757
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.47677593 In vitro selection and characterization of human immunodeficiency virus type 2 with decreased susceptibility to lopinavir Antimicrob. Agents Chemother. 51 3075-3080 2007 Human immunodeficiency virus 2 17576848
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.47677596 Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors Antimicrob. Agents Chemother. 51 604-610 2007 Human immunodeficiency virus 2 17116674
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.47644057 Synthetic HIV-2 protease cleaves the GAG precursor of HIV-1 with the same specificity as HIV-1 protease Arch. Biochem. Biophys. 277 306-311 1990 Human immunodeficiency virus 2 2178555
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.47667530 HIV protease cleaves poly(A)-binding protein Biochem. J. 396 219-226 2006 Human immunodeficiency virus 2 16594896
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.47644068 HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase Biochem. J. 346 305-311 2000 Human immunodeficiency virus 2 -
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.47678937 Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database BMC Infect. Dis. 8 21 2008 Human immunodeficiency virus 2 18304321
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.47679179 Inhibition of HIV-2 protease by HIV-1 protease inhibitors in clinical use Chem. Biol. Drug Des. 71 298-305 2008 Human immunodeficiency virus 2 18312292
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.47644059 Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins FEBS Lett. 281 77-80 1991 Human immunodeficiency virus 2 2015912
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.47753656 Exploring the reasons for decrease in binding affinity of HIV-2 against HIV-1 protease complex using interaction entropy under polarized force field Front. Chem. 6 380 2018 Human immunodeficiency virus 2 30197882
Results 1 - 10 of 29 > >>